3-methyl-2-butenoic acid-2,6,6,9-tetramethyl-11-oxotricyclo-[5.4.0.0(2,8)]-undec-9-ene-3,5-diyl ester - Compound Card

3-methyl-2-butenoic acid-2,6,6,9-tetramethyl-11-oxotricyclo-[5.4.0.0(2,8)]-undec-9-ene-3,5-diyl ester

Select a section from the left sidebar

3-methyl-2-butenoic acid-2,6,6,9-tetramethyl-11-oxotricyclo-[5.4.0.0(2,8)]-undec-9-ene-3,5-diyl ester

Structure
Zoomed Structure
  • Family: Plantae - Cannabaceae
  • Kingdom: Plantae
  • Class: Fatty Acid
Canonical Smiles C12C3(C(CC(C(C1C3C(=CC2=O)C)(C)C)OC(=O)C=C(C)C)OC(=O)C=C(C)C)C
InChI InChI=1S/C25H34O5/c1-13(2)9-19(27)29-17-12-18(30-20(28)10-14(3)4)25(8)21-15(5)11-16(26)22(25)23(21)24(17,6)7/h9-11,17-18,21-23H,12H2,1-8H3
InChIKey ZDKCXNNOQGBPAU-UHFFFAOYSA-N
Formula C25H34O5
HBA 5
HBD 0
MW 414.54
Rotatable Bonds 4
TPSA 69.67
LogP 4.57
Number Rings 3
Number Aromatic Rings 0
Heavy Atom Count 30
Formal Charge 0
Fraction CSP3 0.64
Exact Mass 414.24
Number of Lipinski Rule Violations 0
# Species Family Kingdom NCBI Taxonomy ID
1 Celtis africana Cannabaceae Plantae 266494

Showing of synonyms

  • Kudzanai IT, Evonia KN, et al. (2020). Antibacterial activity and gas chromatography mass spectrometry (GC–MS)-based metabolite profiles of Celtis africana and its endophytic extracts. Industrial Crops and Products, 2020,157, 112933. [View]
Pubchem: 14395223

No compound-protein relationship available.

Structure

SMILES: O=C1C=CC(C2C13)C3CCCC2

Level: 0

Mol. Weight: 414.54 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-4.4
Human Oral Bioavailability 20%
Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-4.61
Human Oral Bioavailability 50%
Non-Bioavailable
P-Glycoprotein Inhibitor
Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
-2.95

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
0.86
Plasma Protein Binding
34.67
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Non-Substrate
OATP1B1
Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
9.79
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Safe
Bee
Toxic
Bioconcentration Factor
1.31
Biodegradation
Safe
Carcinogenesis
Toxic
Crustacean
Toxic
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
0.26
Liver Injury II
Toxic
hERG Blockers
Safe
Daphnia Maga
6.67
Micronucleos
Safe
NR-AhR
Safe
NR-AR
Toxic
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Toxic
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-6.27
Rat (Acute)
2.46
Rat (Chronic Oral)
2.0
Fathead Minnow
4.96
Respiratory Disease
Toxic
Skin Sensitisation
Safe
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Toxic
SR-p53
Toxic

General Properties

Boiling Point
397.47
Hydration Free Energy
-4.55
Log(D) at pH=7.4
4.03
Log(P)
4.91
Log S
-5.35
Log(Vapor Pressure)
-6.33
Melting Point
146.3
pKa Acid
8.56
pKa Basic
4.34
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
Type IV / VI secretion system DotU domain-containing protein Q9KN50 Q9KN50_VIBCH Vibrio cholerae serotype O1 3 0.9387
CmeR Q7B8P6 Q7B8P6_CAMJU Campylobacter jejuni 3 0.7822

Download SDF